Skip to main content
ExamExplained
NSW Β· Biology
Biology study scene
Β§-Syllabus dot point
NSWBiologySyllabus dot point

Inquiry Question 3: How can the spread of infectious diseases be controlled?

Investigate and assess the effectiveness of pharmaceuticals as treatment strategies for the control of infectious disease, including: antivirals and antibiotics, the development of antibiotic resistance, and the role of immunisation including the impact of vaccination programs in conferring herd immunity

A focused answer to the HSC Biology Module 7 dot point on pharmaceutical control of infectious disease. Covers antibiotic and antiviral mechanisms, the evolution of antibiotic resistance, vaccination types, and the herd immunity threshold with named examples.

Reviewed by: AI editorial process; not yet individually human-reviewed

Have a quick question? Jump to the Q&A page

Jump to a section
  1. What this dot point is asking
  2. The answer
  3. Examples in context

What this dot point is asking

NESA wants you to evaluate pharmaceutical strategies for controlling infectious disease, including antibiotics, antivirals and vaccines, and to explain antibiotic resistance and herd immunity. This is one of the largest dot points in Module 7 and appears in extended responses worth 6 to 9 marks.

The answer

Pharmaceutical control of infectious disease has three main tools: antibiotics (against bacteria), antivirals (against viruses) and vaccines (preventive). Each has strengths and limitations, and each is shaped by the evolutionary biology of the pathogen.

Antibiotics

Antibiotics target structures or processes unique to bacteria, sparing host cells.

Mechanisms of action.

  • Cell wall synthesis inhibitors (penicillin, amoxicillin, cephalosporins) prevent peptidoglycan cross-linking, lysing actively growing bacteria.
  • Protein synthesis inhibitors (tetracycline, erythromycin) bind the bacterial 70S ribosome.
  • DNA replication inhibitors (fluoroquinolones such as ciprofloxacin) target bacterial DNA gyrase.
  • Folate synthesis inhibitors (sulphonamides, trimethoprim) block bacterial vitamin synthesis.

Limitations. Antibiotics do not work against viruses, fungi, protozoa or prions. Many cause side effects by killing beneficial gut bacteria.

How antibiotics act on bacterial-specific targets, and why they do not work on viruses On the left, a bacterial cell shows four labelled antibiotic targets: the peptidoglycan cell wall (blocked by penicillin), the 70S ribosome (blocked by tetracycline), DNA gyrase during DNA replication (blocked by ciprofloxacin), and folate synthesis (blocked by sulphonamides). On the right, a virus is shown entering a human host cell and using the host's own ribosomes to make viral proteins; a crossed-out antibiotic symbol indicates antibiotics have no bacterial target to act on, so they do not affect viruses. How antibiotics work - and why not on viruses Bacterium (antibiotic targets) 70S F cell wall penicillin βœ• 70S ribosome tetracycline βœ• folate synthesis sulphonamide βœ• DNA gyrase ciprofloxacin βœ• Virus inside a host cell human host cell host ribosomes make viral proteins virus abx no bacterial target - antibiotics do nothing to viruses each βœ• = an antibiotic blocking a bacteria-only target

Antivirals

Antivirals target viral-specific enzymes and life-cycle steps.

Mechanisms of action.

  • Reverse transcriptase inhibitors (zidovudine, tenofovir) block HIV's conversion of RNA to DNA.
  • Protease inhibitors (lopinavir, paxlovid) block the cleavage of viral polyproteins.
  • Neuraminidase inhibitors (oseltamivir) prevent influenza release from infected cells.
  • Polymerase inhibitors (remdesivir, sofosbuvir) block viral RNA replication.

Limitations. Antivirals are typically pathogen-specific (an HIV antiviral does not work on influenza). Resistance can develop, especially in RNA viruses with high mutation rates.

Antibiotic resistance

Origin. Random mutations in bacterial DNA occasionally produce a resistance gene (e.g. beta-lactamase that degrades penicillin). In an antibiotic-free environment, resistance confers no advantage. Once antibiotics are applied, natural selection favours resistant individuals: susceptible bacteria die, resistant bacteria reproduce.

The evolution of antibiotic resistance by natural selection, in four stages Four stacked stages. Stage 1: a mixed bacterial population, mostly susceptible (teal) with a few resistant cells (red) that arose by random mutation. Stage 2: an antibiotic is applied. Stage 3: the antibiotic kills the susceptible bacteria, leaving only the resistant cells alive. Stage 4: the resistant survivors reproduce, so the whole population is now resistant. Arrows show progression downward and a caption notes the mutation came first, by chance, and the antibiotic only selected for it. Antibiotic resistance evolves by natural selection susceptible resistant killed 1. Variation: a few cells are already resistant resistance arose by random mutation 2. Selection pressure: antibiotic is applied antibiotic = selection pressure 3. Susceptible cells die; resistant cells survive only resistant cells remain 4. Survivors reproduce: population is resistant resistance allele passed on - next infection no longer responds Key: the mutation came FIRST, by chance. The antibiotic did not create resistance - it selected for it.

Spread. Bacteria reproduce rapidly (every 20 minutes in good conditions) and share genes by horizontal gene transfer.

  • Conjugation. Plasmids carrying resistance genes are transferred between cells via a pilus.
  • Transformation. Bacteria take up free DNA from the environment.
  • Transduction. Bacteriophages carry resistance genes between bacterial hosts.

Consequences. Resistant infections cost lives and treatment dollars. Methicillin-resistant Staphylococcus aureus (MRSA), multi-drug resistant tuberculosis (MDR-TB) and carbapenem-resistant Enterobacteriaceae are major threats. The WHO ranks antibiotic resistance among the top ten threats to global health.

Strategies to slow resistance.

  1. Prescribe only when bacterial infection is confirmed.
  2. Complete the prescribed course.
  3. Reduce agricultural antibiotic use (banned in EU food animals as growth promoters since 2006).
  4. Invest in new antibiotic discovery (a class gap of 1987 to 2015 in approval of truly novel classes).
  5. Improve hospital infection control (handwashing, isolation of resistant cases).
  6. Surveillance programs such as Australia's AURA.

Immunisation and vaccination

Vaccines provide active artificial immunity by exposing the immune system to a pathogen antigen without causing disease, generating memory B and T cells.

Vaccine types.

  • Live attenuated (MMR, oral polio, BCG, varicella). Weakened pathogen replicates briefly. Strong immunity. Not suitable for severely immunocompromised people.
  • Inactivated (influenza, hepatitis A, rabies). Killed pathogen. Safer but often needs boosters.
  • Subunit / toxoid (tetanus, diphtheria, hepatitis B, HPV). Specific antigen or inactivated toxin.
  • mRNA (COVID-19 vaccines, in development for flu and HIV). mRNA encoding a pathogen antigen is delivered in a lipid nanoparticle. The host's cells produce the antigen and trigger immunity.
  • Viral vector (some COVID-19 and Ebola vaccines). A harmless virus delivers the pathogen antigen gene.

Herd immunity

When a high enough proportion of a population is immune, transmission chains break and even unvaccinated individuals are protected.

Threshold. The proportion of the population that must be immune is approximately 1 - 1/R0.

  • Measles (R0 = 12 to 18): 92 to 95 per cent.
  • COVID-19 ancestral strain (R0 = 2 to 3): 50 to 67 per cent. Higher for Delta and Omicron variants.
  • Polio (R0 = 5 to 7): 80 to 86 per cent.

Herd immunity: an infection spreads widely in a poorly vaccinated population but is contained in a highly vaccinated one Two grids of people compared. On the left, a population with low vaccination coverage: one infected person (red) spreads to many susceptible unvaccinated people (grey), shown by transmission lines reaching across the grid. On the right, a population with high vaccination coverage: most people are immune (green), so when one person is infected the transmission chains are blocked by surrounding immune individuals and even the few unvaccinated people are protected. Herd immunity breaks transmission chains vaccinated / immune unvaccinated infected Low coverage below threshold - outbreak spreads most people susceptible - chains reach almost everyone High coverage above threshold - outbreak contained immune neighbours block spread - the unvaccinated person is protected When immune fraction β‰₯ 1 βˆ’ 1/Rβ‚€, each case infects < 1 new person on average so transmission chains die out and even the unvaccinated are shielded.

Benefits.

  • Protects those who cannot be vaccinated (newborns, immunocompromised, severely allergic).
  • Enables eradication (smallpox 1980; polio close).
  • Reduces selection pressure for new variants.

Risks of falling below the threshold. Vaccine hesitancy or supply gaps can drop coverage below the herd immunity threshold. Measles outbreaks resurged in 2019 in parts of Europe, North America and the Pacific where coverage had fallen.

Examples in context

Example 1. Tasmanian gonorrhoea resistance crisis 2022-2023. Neisseria gonorrhoeae has progressively evolved resistance to every front-line antibiotic since penicillin in the 1940s, then ciprofloxacin in the 1990s, and most recently ceftriaxone in some strains. In 2022 and 2023, Tasmanian sexual health clinics reported clusters of ceftriaxone-resistant gonorrhoea, prompting an Australian Sexually Transmissible Infections and HIV Surveillance Report. The Royal Australian College of General Practitioners updated guidelines to require culture-based sensitivity testing before treatment in suspected resistant cases. The mechanism is mutation in the penA gene encoding the antibiotic's target penicillin-binding protein 2, plus horizontal acquisition of resistance plasmids. The case illustrates how strong directional selection (antibiotic use) and rapid bacterial evolution produce resistance within years.

Example 2. Measles vaccination and herd immunity in NSW. Measles is one of the most contagious diseases known, with a basic reproduction number (R0) of 12 to 18. To achieve herd immunity (the threshold above which an introduced case cannot sustain an outbreak), vaccination coverage must exceed 1 minus 1/R0, which means roughly 92 to 94 percent of the population must be immune. NSW Health records routine MMR (measles-mumps-rubella) coverage above 95 percent for two-year-olds. When pockets of coverage drop below 90 percent (as in some Northern NSW communities in 2014), measles outbreaks recur. The Bourke and Lismore 2014 outbreak resulted in 26 cases and demonstrated that herd immunity is fragile and locality-dependent.

Graded practice questions (with full marking-style solutions) and short fluency drills for this dot point are in the question bank above - they cover antibiotic and antiviral mechanisms, resistance by natural selection, vaccine types, and the herd-immunity threshold calculation.

Exam-style practice questions

Practice questions written in the style of NESA exam questions on this dot point, with worked answer explainers. The year tag is the paper they imitate, not the source.

2023 HSC5 marksTetanus vaccines were introduced in 1953, reducing case numbers, with most cases now in people aged 65 and over. A graph shows the tetanus vaccination schedule (antibody level rising above the 'immune' threshold after each of 5 doses given through childhood). Assess the use of vaccinations and the vaccination schedule. Use the data provided to support your answer.
Show worked answer β†’

Top band (5) needs a comprehensive, data-supported judgement. Key points from the guidelines:

  • Vaccinations initiate an immune response using a form of the pathogen/antigen that does not cause infection.
  • From the graph, the more booster shots, the longer the person stays immune (each dose lifts antibody level above the immune threshold).
  • Cases occurring in people over 65 result from not having a booster for a long time (immunity wanes).
  • The reduction in tetanus cases shows vaccinations are effective, while the recurring schedule maintains immunity.

Judgement: vaccinations and the booster schedule are effective/valuable. Marker feedback: make an actual judgement (don't just describe the graph) and use all the stimulus.

Source: NESA 2023 HSC Biology examination and marking guidelines.

2022 HSC5 marksJelly Bush honey has a high level of methylglyoxal, known to help fight infection. Design a safe procedure that a scientist could use in a laboratory to investigate the effectiveness of Jelly Bush honey as a pharmaceutical to inhibit bacterial growth, using agar plates.
Show worked answer β†’

Full marks (5) require a valid, safe, controlled agar-plate procedure. A strong design includes:

  • Inoculate agar plates with a pure culture of a known bacterium (spread evenly).
  • Apply discs/wells soaked in honey at one or more concentrations; include a control (e.g. a disc with no honey, or sterile water) for comparison.
  • Control variables: same bacterial species/concentration, agar type, plate size, incubation temperature and time.
  • Incubate (e.g. 24–48 h) and measure the zone of inhibition (clear area) around each disc; repeat for reliability.
  • Safety: work aseptically, sterilise equipment, seal plates and do not reopen them after incubation, wear gloves, disinfect the bench.

Marker feedback: inoculate with a pure culture, compare to a control, and avoid opening dishes after incubation.

Source: NESA 2022 HSC Biology examination and marking guidelines.

2021 HSC7 marksA study compared 8134 children who received the measles vaccine with 8134 unvaccinated children (matched for age, sex, dwelling, siblings, maternal education). Graphs show measles cases in each group, and a table shows deaths by cause (measles, diarrhoea/dysentery, oedema, fever) for both groups. 'A vaccine only protects the community against a specific disease.' Analyse the data with reference to this statement.
Show worked answer β†’

Top band (7) needs analysis of the data with arguments for and against the statement. Key points from the guidelines:

  • Supports the statement (specific protection): the measles vaccine greatly reduces measles β€” incidence in vaccinated children is very low/zero vs unvaccinated, and only 2 vaccinated children died of measles vs 40 unvaccinated. Since groups were matched, the vaccine is likely responsible.
  • Against the statement (non-specific benefits): vaccinated children also died less from other diseases β€” about half the rate from diarrhoea/dysentery and under one-third from oedema β€” suggesting protection beyond the specific disease. But oedema numbers are small, and fever differences are minor, so protection is not uniform.
  • Overall: the vaccinated group had about half the total mortality, so the statement requires qualification.

Marker feedback: use all the stimulus and manipulate the data to build arguments both for and against.

Source: NESA 2021 HSC Biology examination and marking guidelines.

2020 HSC3 marksOutline a benefit and a limitation of using pharmaceuticals such as antibiotics to treat infectious disease.
Show worked answer β†’

3 marks for outlining both a benefit and a limitation. Sample answer: Benefit β€” antibiotics treat bacterial infections by inhibiting bacterial growth (or killing bacteria). Limitation β€” antibiotic resistance in bacteria is becoming increasingly common, reducing the effectiveness of many antibiotics. 2 marks for identifying both, or outlining only one. Marker feedback: match the drug to the right pathogen (antibiotics work on bacteria, not viruses); don't confuse antibiotics with antibodies; and note that the bacteria (not the patient's body) develop resistance. Source: NESA 2020 HSC Biology examination and marking guidelines.

Practice questions

Original practice questions graded from foundation to exam level, each with a full worked solution. Try them before revealing the solution.

foundation2 marksExplain why antibiotics are effective against bacteria but not against viruses.
Show worked solution β†’

1 mark - what antibiotics target. Antibiotics target structures or processes unique to bacteria (for example the peptidoglycan cell wall, the bacterial 70S ribosome or bacterial DNA gyrase).

1 mark - why viruses are unaffected. Viruses lack these structures and use the host cell's machinery to replicate, so there is nothing for an antibiotic to act on without harming the host.

The mark hinges on naming a bacterial-specific target AND stating that viruses use host machinery. Answers that only say "viruses are different" cap at 1 mark.

foundation3 marksOutline how a vaccine produces immunity to a disease without causing the disease itself.
Show worked solution β†’
1 mark - the stimulus
A vaccine introduces a pathogen antigen in a form that does not cause disease (a weakened/inactivated pathogen, a subunit, a toxoid, or mRNA encoding an antigen).
1 mark - the primary response
This triggers an adaptive immune response: B and T lymphocytes specific to the antigen are activated and proliferate.
1 mark - memory
The response generates memory B and T cells, so on later exposure to the real pathogen the response is faster and stronger (secondary response), clearing the pathogen before disease develops.

All three stages (safe antigen, specific response, memory cells) are needed for full marks.

foundation3 marksA disease has a basic reproduction number (R0) of 5. Calculate the herd immunity threshold, and state one group that herd immunity protects.
Show worked solution β†’
1 mark - the formula
Herd immunity threshold =1βˆ’1R0= 1 - \tfrac{1}{R_0}.
1 mark - the calculation
1βˆ’15=0.81 - \tfrac{1}{5} = 0.8, so 80 per cent of the population must be immune.
1 mark - who is protected
Herd immunity protects people who cannot be vaccinated, for example newborns, the severely immunocompromised, or those with severe vaccine allergies (any one).

Showing the substitution into the formula is required; a bare "80%" without working caps at 2 marks.

core4 marksExplain how the use of antibiotics leads to the evolution of antibiotic resistance in a bacterial population. Use the principles of natural selection in your answer.
Show worked solution β†’
1 mark - variation
Within a bacterial population there is genetic variation: random mutations mean a few bacteria already carry a resistance allele (e.g. one producing beta-lactamase) before the antibiotic is used.
1 mark - selection pressure
Applying the antibiotic is a selection pressure that kills the susceptible bacteria, while the resistant bacteria survive.
1 mark - differential reproduction
The surviving resistant bacteria reproduce (rapidly, by binary fission), passing the resistance allele to offspring, so its frequency increases in the population.
1 mark - outcome / spread
Over generations the population becomes predominantly resistant; resistance can also spread between bacteria by horizontal gene transfer (conjugation, transformation, transduction).

Band 6 answers stress that the mutation arises randomly and beforehand - the antibiotic selects for it, it does not cause it. Intentional language ("bacteria adapt to survive") loses the natural-selection mark.

core4 marksCompare the mechanism of action of antibiotics with that of antivirals, and explain why developing antivirals is generally more difficult.
Show worked solution β†’
Antibiotics (1 mark)
Antibiotics act on bacterial-specific targets (peptidoglycan wall synthesis, the 70S ribosome, DNA gyrase, folate synthesis) that have no human equivalent, so the drug can kill or inhibit the bacterium with little harm to the host.
Antivirals (1 mark)
Antivirals block viral-specific enzymes or life-cycle steps (e.g. reverse transcriptase, protease, neuraminidase, viral polymerase) rather than a free-living cell's structures.
The comparison / difficulty (2 marks)
Because viruses replicate inside host cells using host machinery, there are far fewer virus-only targets, so it is hard to harm the virus without harming the host cell. Antivirals are therefore usually narrowly pathogen-specific, and high mutation rates in RNA viruses make resistance and evasion common, complicating development.

Full marks need a genuine comparison (both drug classes addressed) plus the host-machinery reason for the difficulty.

core5 marksDescribe three mechanisms by which antibiotic-resistance genes spread through and between bacterial populations, and outline two strategies used to slow the spread of resistance.
Show worked solution β†’

Mechanisms (3 marks, 1 each).

  • Conjugation - a plasmid carrying the resistance gene is transferred from one bacterium to another through a pilus (direct cell-to-cell transfer).
  • Transformation - a bacterium takes up free DNA (including resistance genes) released from dead bacteria in its environment.
  • Transduction - a bacteriophage carries a resistance gene from one bacterial host to another during infection.

(Also creditable as a vertical mechanism: rapid binary fission passing the gene to daughter cells.)

Strategies (2 marks, 1 each - any two).

  • Antibiotic stewardship: prescribe only for confirmed bacterial infection and complete the full course, reducing the selection pressure.
  • Reduce agricultural use of antibiotics as growth promoters.
  • Hospital infection control (handwashing, isolating resistant cases) and surveillance (e.g. Australia's AURA) to limit transmission.

Each named mechanism must include its vector (plasmid/pilus, free DNA, phage) to earn the mark.

exam7 marksAssess the effectiveness of pharmaceuticals (antibiotics, antivirals and vaccines) as strategies for the control of infectious disease.
Show worked solution β†’

"Assess" requires a judgement weighing effectiveness against limitations for each tool, supported by examples, with an overall conclusion. A Band 6 response is structured and evidenced, not a list.

Antibiotics (1-2 marks)
Highly effective against bacterial infection by targeting bacterial-specific structures (cell wall, 70S ribosome), and cheap and widely available - they have dramatically reduced deaths from bacterial disease. Limitations: ineffective against viruses/fungi/protozoa, kill beneficial gut flora, and their long-term effectiveness is undermined by the evolution of resistance (e.g. MRSA, MDR-TB) through natural selection and horizontal gene transfer.
Antivirals (1-2 marks)
Effective against specific viruses by blocking viral enzymes (e.g. oseltamivir for influenza, reverse-transcriptase inhibitors for HIV), turning some lethal infections into manageable conditions. Limitations: narrowly pathogen-specific, do not eradicate latent virus, and resistance arises readily in high-mutation RNA viruses.
Vaccines (1-2 marks)
The most effective tool for prevention: they pre-arm the adaptive immune system with memory cells, can achieve herd immunity above the 1βˆ’1R01 - \tfrac{1}{R_0} threshold, and have eradicated smallpox (1980) and nearly eliminated polio. Limitations: preventive not curative, require high coverage, some types unsuitable for the immunocompromised, and effectiveness is threatened by vaccine hesitancy.
Judgement (1-2 marks)
A supported conclusion: pharmaceuticals are highly effective overall, with vaccines the most valuable (prevention plus herd immunity) and antibiotics/antivirals essential for treatment, but their effectiveness is conditional on responsible use (stewardship) and high vaccination coverage to counter resistance and waning immunity. An answer lacking an explicit, evidence-based judgement caps below full marks.
exam6 marksA new respiratory virus has a basic reproduction number (R0) of 4. A vaccine is developed that is 80 per cent effective. Calculate the herd immunity threshold and the minimum vaccination coverage required, then discuss why reaching this coverage may be difficult in practice.
Show worked solution β†’
Herd immunity threshold (1 mark)
1βˆ’1R0=1βˆ’14=0.751 - \tfrac{1}{R_0} = 1 - \tfrac{1}{4} = 0.75, so 75 per cent of the population must be immune.
Coverage adjustment for efficacy (2 marks)
Because the vaccine is only 80 per cent effective, the proportion vaccinated must exceed the threshold: minimum coverage =0.750.80=0.9375= \tfrac{0.75}{0.80} = 0.9375, i.e. about 94 per cent must be vaccinated for coverage alone to reach the threshold.
Why this is hard (2-3 marks - any of)
  • Vaccine hesitancy / misinformation lowers uptake below 94 per cent.
  • Access and supply gaps (cost, cold-chain, remote communities) leave pockets unvaccinated, and herd immunity is locality-dependent, so local clusters can still spread.
  • Some people cannot be vaccinated (immunocompromised, allergic), and immunity may wane, requiring boosters.
  • If R0 rises (a more transmissible variant), the required threshold rises too.

Full marks need both correct calculations (75% threshold, ~94% coverage) shown with working, plus at least two distinct, well-explained barriers.

ExamExplained